Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NovImmune
Biotech
Novimmune unit nabs Takeda milestone payment for hemophilia work
Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.
Ben Adams
Feb 14, 2020 9:10am
Sobi to buy Novimmune R&D assets, lay off 90 staff
Jun 12, 2019 9:25am
Novimmune, TG ally to take CD47-CD19 bispecific into clinic
Jun 20, 2018 9:12am
Tiziana plots NASH combo after buying Novimmune asset
Jan 3, 2017 7:35am
Novimmune’s billionaire backer happy to hang fire on IPO until market improves
May 19, 2016 6:15am
Novimmune raises CHF 30M in second financing of 2016
May 11, 2016 11:44am
